ImpactRx Promotes Industry Veteran to Senior Vice President, Client Services Operations
Mark Degatano Brings Thirty Years of Pharmaceutical Industry Experience to his New Role.
Mount Laurel, NJ, April 09, 2011 --(PR.com)-- ImpactRx, the only pharmaceutical market research company utilizing a longitudinal network of high-value iPhone-connected physicians to capture and report prescribing decision data, is pleased to announce the appointment of Mark Degatano to Senior Vice President, Client Services Operations. He will lead the Advanced Analytics, Custom Market Research, and Syndicated Analytic support teams.
ImpactRx is the pioneer in measuring the impact of pharmaceutical promotion on physician prescribing behavior, capturing over one million details and three million treatment decisions annually. ImpactRx combines its research with custom solution analytics and promotion response modeling to provide vital sales and marketing data to its clients.
“We are confident that Mark will continue to enhance and expand the already superior services we offer to our clients,” said Richard Altus, President and CEO. “His deep experience and proven track record in market research, advanced analytics, and sales force effectiveness will continue to empower key pharmaceutical and biotech decision makers to make insightful decisions before, during and after the launch of their products.”
Prior to joining ImpactRx, Mr. Degatano was with Merck for 24 years where his last position was Vice President, U.S. Human Health Customer Insights. His organization supported sales in excess of $10 billion and provided analytical support for Merck’s developmental and promoted products which spanned over 20 therapeutic areas. Mr. Degatano began his career as a consultant with Arthur D. Little, Inc. providing analytic and market research services.
Mr. Degatano received his BA in Mathematics and MA in Statistics, both from Boston University.
About ImpactRx Founded in 2000 and headquartered in Mount Laurel, N.J., ImpactRx’s longitudinal panels of high value, iPhone-connected physicians are the exclusive source of continuously captured promotion and treatment data. Through its proprietary methodology, the Company annually captures one million details and three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers. To learn more, visit www.impactrx.com
###
ImpactRx is the pioneer in measuring the impact of pharmaceutical promotion on physician prescribing behavior, capturing over one million details and three million treatment decisions annually. ImpactRx combines its research with custom solution analytics and promotion response modeling to provide vital sales and marketing data to its clients.
“We are confident that Mark will continue to enhance and expand the already superior services we offer to our clients,” said Richard Altus, President and CEO. “His deep experience and proven track record in market research, advanced analytics, and sales force effectiveness will continue to empower key pharmaceutical and biotech decision makers to make insightful decisions before, during and after the launch of their products.”
Prior to joining ImpactRx, Mr. Degatano was with Merck for 24 years where his last position was Vice President, U.S. Human Health Customer Insights. His organization supported sales in excess of $10 billion and provided analytical support for Merck’s developmental and promoted products which spanned over 20 therapeutic areas. Mr. Degatano began his career as a consultant with Arthur D. Little, Inc. providing analytic and market research services.
Mr. Degatano received his BA in Mathematics and MA in Statistics, both from Boston University.
About ImpactRx Founded in 2000 and headquartered in Mount Laurel, N.J., ImpactRx’s longitudinal panels of high value, iPhone-connected physicians are the exclusive source of continuously captured promotion and treatment data. Through its proprietary methodology, the Company annually captures one million details and three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers. To learn more, visit www.impactrx.com
###
Contact
ImpactRx, Inc
Jennifer Aguilar
215-230-9024
www.impactrx.com
Jennifer Aguilar
215-230-9024
www.impactrx.com
Contact
Categories